Not all people with CLL need therapy. Despite all modern advances, the iwCLL even now recommends watchful observation for clients with asymptomatic condition.86 This advice relies on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Pemain baru pasti akan https://zalmayc952los4.blogdun.com/profile